Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer

Authors: Minne, Rachel L., Luo, Natalie Y., Traynor, Anne M., Huang, Minxuan, DeTullio, Luisina, Godden, Jen, Stoppler, Melissa, Kimple, Randall J., Baschnagel, Andrew M.

Source: In Clinical Lung Cancer September 2024 25(6):567-576

Evaluation of a Novel MET-Targeting Camelid-Derived Antibody in Head and Neck Cancer.

Authors: Minne, Rachel L., Luo, Natalie Y., Mork, Caroline M., Wopat, Madalynn R., Esbona, Karla, Javeri, Saahil, Nickel, Kwangok P., Hernandez, Reinier, LeBeau, Aaron M., Kimple, Randall J., Baschnagel, Andrew M.

Source: Molecular Pharmaceutics; 12/2/2024, Vol. 21 Issue 12, p6376-6384, 9p

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer

Authors: Luo, Natalie Y., Minne, Rachel L., Gallant, Joseph P., Gunaratne, Gihan S., West, Jayden L., Javeri, Saahil, Robertson, Austin J., Lake, Eric W., Engle, Jonathan W., Mixdorf, Jason C., Aluicio-Sarduy, Eduardo, Nickel, Kwang P., Hernandez, Reinier, Kimple, Randall J., Baschnagel, Andrew M., LeBeau, Aaron M.

Source: Bioconjugate Chemistry; March 2024, Vol. 35 Issue: 3 p389-399, 11p